Insmed Inc. buy Wells Fargo & Company
Start price
20.10.25
/
50%
€143.00
Target price
20.10.26
€146.65
Performance (%)
-18.31%
Price
10.08.26
?
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.31%. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 1.128% | 1.128% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $171.00 price target on the stock.
Ratings data for INSM provided by MarketBeat